Found: 10
Select item for more details and to access through your institution.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 1125, doi. 10.1007/s15010-023-02169-7
- By:
- Publication type:
- Article
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E312, doi. 10.1002/ajh.26626
- By:
- Publication type:
- Article
High frequency of hyperglycaemia observed during CAR T‐cell treatment.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 2, p. 1, doi. 10.1111/dme.14969
- By:
- Publication type:
- Article
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01022-w
- By:
- Publication type:
- Article
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5443, doi. 10.3390/cancers15225443
- By:
- Publication type:
- Article
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
- By:
- Publication type:
- Article
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5530, doi. 10.3390/cancers14225530
- By:
- Publication type:
- Article
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3240
- By:
- Publication type:
- Article
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231154706
- By:
- Publication type:
- Article